COLLETTE UTLEY: Open Payments
NPI 1356343560 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,992 in 79 payments from 21 companies in 2025. Trend: 2023 $2,534 · 2024 $5,013 · 2025 $3,992
Food & beverage: $2,254Consulting: $1,625Education: $113
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $1,885 |
| Galderma Laboratories, L.P. | 7 | $446 |
| Janssen Biotech, Inc. | 9 | $338 |
| GENZYME CORPORATION | 4 | $275 |
| Incyte Corporation | 9 | $195 |
| ABBVIE INC. | 11 | $190 |
| UCB, Inc. | 9 | $138 |
| Arcutis Biotherapeutics, Inc. | 1 | $121 |
| Almirall LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 1 | $45 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, OPZELURA, SKYRIZI, Bimzelx, Zoryve, COSENTYX.
Industry payments across TN — which companies pay providers there.
